Dutacatib
Dutacatib is inhibitor for SARS-CoV-2 3CLpro and cathepsin K, which exhibits antiviral activity and ameliorates the cancer-induced bone diseases[1][2].
Product Specifications
CAS Number
501000-36-8
UNSPSC
12352005
Target
Cathepsin; SARS-CoV; Virus Protease
Type
Reference compound
Related Pathways
Anti-infection; Metabolic Enzyme/Protease
Applications
COVID-19-anti-virus
Field of Research
Cancer; Infection
Assay Protocol
https://www.medchemexpress.com/dutacatib.html
Smiles
O=C(NCC1=CN=C(C#N)N=C1NCC(C)(C)C)C2=CC=C(N3CCN(C)CC3)C=C2
Molecular Formula
C23H31N7O
Molecular Weight
421.54
References & Citations
[1]Sousa S, et al., Bone-Targeted Therapies in Cancer-Induced Bone Disease. Calcif Tissue Int. 2018 Feb;102 (2) :227-250. |[2]Dayan Elshan NGR, et al., Discovery of CMX990: A Potent SARS-CoV-2 3CL Protease Inhibitor Bearing a Novel Warhead. J Med Chem. 2024 Feb 22;67 (4) :2369-2378.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6484299-01 0.1 mL
Keratinocyte Growth Factor (KGF, Fibroblast Growth Factor 7, FGF-7) (MaxLight 405)
Sign In for Pricing
View Details MBS6484299-02 5x 0.1 mL
Keratinocyte Growth Factor (KGF, Fibroblast Growth Factor 7, FGF-7) (MaxLight 405)
Sign In for Pricing
View Details 
A0200-51 1 mg
2-Acetamido-2-deoxy-4-O- (b-D-mannopyranosyl) -D-glucose (Man1-b-4GlcNAc)
Sign In for Pricing
View Details 